Nunzia Matrone
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Journal: Oncotarget
Published: August 29, 2025
TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.
Journal: Cancer research
Published: November 07, 2024
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 12, 2020
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Journal: Medical oncology (Northwood, London, England)
Published: August 28, 2020
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 22, 2020
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 01, 2019
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Journal: Cancers
Published: August 09, 2019
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 06, 2019
A dynamic link between H/ACA snoRNP components and cytoplasmic stress granules.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: January 17, 2019
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 27, 2018
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: June 14, 2018
A functional connection between dyskerin and energy metabolism.
Journal: Redox biology
Published: July 26, 2017
Last Updated: 09/26/2026